Evelo Biosciences Inc

NASDAQ:EVLO 3:26:42 PM EDT

1.83

+0.06 (+3.39%)

Evelo Biosciences Inc Stock, NASDAQ:EVLO

620 Memorial Drive, 5th floor, Cambridge, Massachusetts 02139

United States of America

Phone: +1.617.577.0300

Number of Employees: 122

http://www.evelobio.com

Description

Evelo Biosciences, Inc. operates as a clinical stage biotechnology company, which engages in the development of orally delivered investigational medicines. Its portfolio includes EDP1066 and EDP1815 for the treatment of inflammatory diseases, EDP2939 for inflammation, and EDP1908 for oncology. The company was founded by Noubar B. Afeyan and David A. Berry in 2014 and is headquartered in Cambridge, MA.